Publicaties
PREVENTION OF TUNNELED CUFFED CATHETER DYSFUNCTION WITH PROPHYLACTIC USE OF TAUROLIDINE LOCKING SOLUTION CONTAINING UROKINASE: A PROSPECTIVE AND RANDOMIZED PLACEBO-CONTROLLED TRIAL Vrije Universiteit Brussel
Prevention of Tunneled Cuffed Hemodialysis Catheter-Related Dysfunction and Bacteremia by a Neutral-Valve Closed-System Connector: A Single-Center Randomized Controlled Trial Vrije Universiteit Brussel
Study Design: Single-center randomized controlled trial. Setting &
...
Efficacy of urokinase lock to treat thrombotic dysfunction of tunneled hemodialysis catheters Vrije Universiteit Brussel
Background: There are few data to inform decisions about the optimal management of occluded tunneled cuffed hemodialysis catheters with thrombolytic locking solutions. The effect of dose, dwell-time, and number of administrations remains controversial. Methods: In this retrospective single-center review of tunneled cuffed catheters used between 2010 and 2014, restoration of blood flow as well as pre- and post-pump pressures after either short ...
Urokinase-containing locking solution in the prevention of dialysis catheter dysfunction: a double blind randomized controlled trial Vrije Universiteit Brussel Universiteit Gent Universiteit Antwerpen
Introduction: The prophylactic use of recombinant tissue plasminogen activator once weekly reduces the incidence rate of tunneled cuffed catheter (TCC) malfunction and bacteremia as compared to the exclusive use of heparin as locking solution. Restricting the use of prophylactic thrombolytic agents to patients with a history of thrombotic TCC malfunction could be more cost effective. We conduct a multicenter, double-blind, randomized ...